After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

When adventurers talk about Mount Everest, most often it's about climbing the world's highest peak. In October, Jim Morrison became the first person to ski down Everest’s most dangerous route. The ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Nov. 13, 2025 — A new film from Oregon Public Broadcasting (OPB) provides an exclusive, inside look at the emotional, historic, and triumphant journey of a group of Indigenous youth paddlers down the ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

WILLIAMSBURG — Williamsburg will host its first fantasy ball this winter with “Persephone’s Descent,” an immersive event inspired by the Greek goddess of the underworld. The ball is scheduled to be ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Dr. James McCaffrey presents a complete end-to-end demonstration of the kernel ridge regression technique to predict a single numeric value. The demo uses stochastic gradient descent, one of two ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...